Aristina Papanota

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersNuclear physicsMedical infection agents (incl. prions)Medical mycologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2025
Molecular Prognostic Factors in Uterine Serous Carcinomas: A Systematic Review.

Anna Svarna, Michalis Liontos, Alkistis Papatheodoridi

|Sep 30, 2022
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More.

Ioannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis

|Dec 24, 2021
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.

Paraskevi Karousi, Aristea-Maria Papanota, Pinelopi I Artemaki

|Dec 10, 2021
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.

Aristea-Maria Papanota, Paraskevi Karousi, Christos K Kontos

|Aug 27, 2021
Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

Ioannis V Kostopoulos, Evangelos Eleutherakis-Papaiakovou, Pantelis Rousakis

|Aug 07, 2021
A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.

Aristea-Maria Papanota, Panagiotis Tsiakanikas, Christos K Kontos

Pageof 1

Frequent Collaborators

6 joint publications

Meletios-Athanasios Dimopoulos

5 joint publications

Ioannis Ntanasis-Stathopoulos

5 joint publications

Evangelos Terpos

3 joint publications

Christos K Kontos